CD8A and neoplasm: Staining with recombinant MHC-I tetramer complexes presenting the CT26 tumor antigen GP70 revealed significantly higher levels of tumor-infiltrating GP70-specific CD8+ T cells in G9668-treated mice (Fig. 5 G).